Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.58 |
| ▸ | CES1 | P23141 | 2/20 | 0.58 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | TERT | O14746 | 3/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.51 |
| ▸ | PPARG | P37231 | 3/20 | 0.51 |
| ▸ | PPARD | Q03181 | 3/20 | 0.51 |
| ▸ | PPARA | Q07869 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | BLM | P54132 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | FABP4 | P15090 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | GMNN | O75496 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8343681 | 1.00 | FAAH (0.58) | FAAHCES1DGKATERTPTPN1 | |
| SCHEMBL8344661 | 1.00 | FAAH (0.58) | FAAHCES1DGKATERTPTPN1 | |
| SCHEMBL8343680 | 1.00 | FAAH (0.58) | FAAHCES1DGKATERTPTPN1 | |
| SCHEMBL19873069 | 1.00 | FAAH (0.58) | FAAHCES1DGKATERTPTPN1 | |
| Octane SCHEMBL16439984 | 1.00 | FAAH (0.58) | FAAHCES1DGKATERTPTPN1 | |
| SCHEMBL2179345 | 1.00 | FAAH (0.58) | FAAHCES1DGKATERTPTPN1 | |
| SCHEMBL361243 | 1.00 | FAAH (0.58) | FAAHCES1DGKATERTPTPN1 | |
| SCHEMBL170316 | 1.00 | FAAH (0.58) | FAAHCES1DGKATERTPTPN1 | |
| SCHEMBL8344665 | 1.00 | FAAH (0.58) | FAAHCES1DGKATERTPTPN1 | |
| SCHEMBL29709266 | 1.00 | FAAH (0.58) | FAAHCES1DGKATERTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11684584-B2 | Branched peg molecules and related compositions and methods | GENEVANT SCIENCES GMBH (CH) | 2023-06-27 | — | — | US | disclosed |
| WO-2023006062-A1 | NUCLEIC ACID VACCINES FOR MUTANT CORONAVIRUS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-02-02 | — | — | WO | disclosed |
| US-20220288061-A1 | FORMULATIONS AND TREATMENT METHODS | CAMURUS AB (SE) | 2022-09-15 | — | — | US | disclosed |
| WO-2022152141-A2 | POLYMER CONJUGATED LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2022-07-21 | — | — | WO | disclosed |
| EP-4025184-A1 | FORMULATIONS AND TREATMENT METHODS | Camurus AB (SE) | 2022-07-13 | — | — | EP | disclosed |
| WO-2021043771-A1 | FORMULATIONS AND TREATMENT METHODS | CAMURUS AB (SE) | 2021-03-11 | — | — | WO | disclosed |
| US-20200078313-A1 | BRANCHED PEG MOLECULES AND RELATED COMPOSITIONS AND METHODS | Genevant Sciences GmbH. (CH) | 2020-03-12 | — | — | US | disclosed |
| EP-3562510-A1 | BRANCHED PEG MOLECULES AND RELATED COMPOSITIONS AND METHODS | Genevant Sciences GmbH (CH) | 2019-11-06 | — | — | EP | disclosed |
| WO-2018126084-A1 | BRANCHED PEG MOLECULES AND RELATED COMPOSITIONS AND METHODS | PHASERX, INC. (US) | 2018-07-05 | — | — | WO | disclosed |
| US-9328335-B2 | Method to produce acetyldiacylglycerols (ac-TAGs) by expression of an acetyltransferase gene isolated from Euonymus alatus (burning bush) | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2016-05-03 | — | — | US | disclosed |
| US-20130116462-A1 | METHOD TO PRODUCE ACETYLDIACYLGLYCEROLS (AC-TAGS) BY EXPRESSION OF AN ACETYLTRANSFERASE GENE ISOLATED FROM EUONYMUS ALATUS (BURNING BUSH) | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2013-05-09 | — | — | US | disclosed |
| WO-2011082253-A2 | A METHOD TO PRODUCE ACETYLDIACYLGLYCEROLS (AC-TAGS) BY EXPRESSION OFAN ACETYLTRANSFERASE GENE ISOLATED FROM EUONYMUS ALATUS (BURNING BUSH) | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2011-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200078313-A1 | BRANCHED PEG MOLECULES AND RELATED COMPOSITIONS AND METHODS | CLTB, EGFR, HDGF | FAAH 3219/4885CES1 1313/4885DGKA 657/4885 |
| US-11684584-B2 | Branched peg molecules and related compositions and methods | CLTB, EGFR, HDGF | FAAH 3219/4885CES1 1313/4885DGKA 657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.